An Entity of Type: chemical substance, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Bovhyaluronidase azoximer, sold under the brand name Longidaze, is a conjugate of proteolytic enzyme hyaluronidase with high- molecular weight copolymer that forms a component of combination therapy regimens for treatment and prevention of diseases associated with connective tissue hyperplasia.The most frequently observed adverse reactions seen with bovhyaluronidase azoximer include pain at site of injection and injection site reaction n such as skin redness, itching and oedema. All local reactions resolve themselves in 48 – 72 hours.

Property Value
dbo:abstract
  • Bovhyaluronidase azoximer, sold under the brand name Longidaze, is a conjugate of proteolytic enzyme hyaluronidase with high- molecular weight copolymer that forms a component of combination therapy regimens for treatment and prevention of diseases associated with connective tissue hyperplasia.The most frequently observed adverse reactions seen with bovhyaluronidase azoximer include pain at site of injection and injection site reaction n such as skin redness, itching and oedema. All local reactions resolve themselves in 48 – 72 hours. (en)
dbo:alternativeName
  • Longidaze (en)
dbo:wikiPageExternalLink
dbo:wikiPageID
  • 67558499 (xsd:integer)
dbo:wikiPageLength
  • 21105 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1099083896 (xsd:integer)
dbo:wikiPageWikiLink
dbp:bioavailability
  • not less than 90% (en)
dbp:caption
  • conjugate of proteolytic enzyme hyaluronidase (en)
dbp:drugName
  • Bovhyaluronidase azoximer (en)
dbp:eliminationHalfLife
  • 129600.0
dbp:excretion
  • renal (en)
dbp:legalStatus
  • ЛС-000764 (en)
dbp:pronounce
  • Bovhyaluronidase azoximer (en)
dbp:routesOfAdministration
  • intramuscular injection (en)
dbp:tradename
  • Longidaze (en)
dbp:wikiPageUsesTemplate
dcterms:subject
rdf:type
rdfs:comment
  • Bovhyaluronidase azoximer, sold under the brand name Longidaze, is a conjugate of proteolytic enzyme hyaluronidase with high- molecular weight copolymer that forms a component of combination therapy regimens for treatment and prevention of diseases associated with connective tissue hyperplasia.The most frequently observed adverse reactions seen with bovhyaluronidase azoximer include pain at site of injection and injection site reaction n such as skin redness, itching and oedema. All local reactions resolve themselves in 48 – 72 hours. (en)
rdfs:label
  • Bovhyaluronidase azoximer (en)
owl:sameAs
prov:wasDerivedFrom
foaf:isPrimaryTopicOf
foaf:name
  • Bovhyaluronidase azoximer (en)
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License